Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi-Aventis begins shake-up

This article was originally published in Scrip

Executive Summary

Chris Viehbacher, the newly appointed CEO ofSanofi-Aventis, has implemented a number of organisational changes just days after taking up the position. Jean-Claude Leroy, executive vice-president finance and legal, is to leave his position and will be replaced by Laurence Debroux as senior vice-president and chief financial officer. Sanofi-Aventis has also appointed Karen Linehan senior vice-president of legal affairs and general counsel. Ms Debroux and Ms Linehan, who are both members of the executive committee and the group management committee, will now report directly to Mr Viehbacher. Mr Viebacher joined Sanofi-Aventis at the beginning of this month after leaving his position asGlaxoSmithKline's president of North American pharmaceutical operations.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC008024

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel